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InTRODUcTIOn
The goals of procedural sedation (PSA) stretch far beyond 
providing just sedation and analgesia. Practices need to 
strive to treat adults and children with dignity, decreasing 
their anxiety levels, providing adequate pain control, pre-
venting adverse events, while maintaining proper cardio-
respiratory function.1 Safety is crucial.
Protection of the airway is vital to ensure patient safety. In 
dental sedation, the airway is usually shared by the sedation 
practitioner and the dentist. Understanding the importance 
of the airway and a basic knowledge of the anatomy are nec-
essary. Protecting the patient against hypoxia is crucial.
This article will review critical aspects of laryngospasm (a 
form of airway obstruction), which may threaten patient 
safety, and will discuss how to rescue the patient during 
dental sedation.
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DIScUSSIOn
PSA has been proven to be a safe and effective alternative 
to general anaesthesia for anxious patients (adults and 
children) who are undergoing certain surgical procedures 
outside the in-hospital environment. PSA refers to a tech-
nique of administering sedatives or dissociative agents, 
with or without analgesics, that allows patients to tolerate 
unpleasant procedures while cardio-respiratory function 
is fully maintained.2 Behavioural management is an ex-
tremely important component of PSA.
According to Campbell et al, the risks related to office-
based procedural sedation can be divided into three 
groups: inadequate sedation, over sedation/adverse re-
sponse to sedatives or failed sedation.3 
Patient safety begins with patient assessment and prep-
aration. This includes a detailed medical history, clinical 
assessment and a focused airway evaluation before the 
sedation. The patient must meet the requirements for safe 
practice, as only ASA 1 and 2 patients can receive treat-
ment outside the operating theatre.
There are various tools available to establish whether the 
airway will be safe under sedation.1 This article will give 
practical information by defining laryngospasm, the risk 
factors for its development and the treatment thereof. 
Laryngospasm remains an important cause of airway 
obstruction. It can be responsible for significant 
morbidity and even mortality, especially in the paediatric 
population.4 Risk factors for the development of 
laryngospasm can be divided into patient related factors, 
and procedure and sedation-related factors. Patient 
factors include age (young children are especially at 
risk), the reactive airway e.g. after a common cold, upper 
respiratory tract infections or exposure to smoking, 
and, patients undergoing procedures to the larynx or 
pharynx. Sedation risk factors include any stimulation of 
the larynx, for example using suction catheters, or the 
influx of blood, mucus or other secretions.
Laryngospasm is a reflex closure of the upper airway as 
a result of stimulation of the superior laryngeal nerve, re-
sulting in muscle spasm. This protective reflex prevents 
foreign material entering the trachea-bronchial tree but 
can cause hypoxia. It can be partial, allowing some air 
through, (and causing inspiratory stridor), or complete, 
with total absence of breath sounds.5 
Laryngospasm can be self-limiting, but if it persists and is 
left untreated, life-threatening complications can ensue.6 
The best management is prevention. This is done by 
identifying patients at risk as well as careful airway 
management during the sedation.4 Secretions or blood from 
the patient’s mouth as well as dental devices that make use 
of water sprays need to be monitored at all times. 
Prompt identification is the key to successful treatment 
and the sedation practitioner needs to be on the lookout 
for signs and symptoms suggestive of laryngospasm, such 
as: inspiratory stridor, usage of accessory respiratory or 
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abdominal muscles, absence of breath and ultimately symptoms of hypoxia and 
cyanosis. Common complications of laryngospasm include: oxygen desaturation, 
bradycardia, pulmonary aspiration, and even cardiac arrest.5 
Airway manoeuvers can alleviate early laryngospasm. Perform a head tilt and jaw 
thrust while providing 100% oxygen with a positive pressure mask e.g. the Ambu-
bag. Pharmacologic agents such as propofol or muscle relaxants should be used 
only in the hands of experienced sedation practitioners, comfortable in providing a 
secure airway.7 
The management of laryngospasm requires application of knowledge, skills and 
teamwork. Simulation-based education, especially focused on airway management, 
is an area of significant benefit for the practitioner, who of course must undergo 
continuous professional education.4 
The sedation practitioner’s best preparation is anticipation, recognition, and readi-
ness to respond to an adverse event. This is the reason why we advise sedation 
practitioners to seek training in PSA and see that they get airway certification. Basic 
manoeuvers e.g. jaw thrust, are usually sufficient to rescue the airway, but  adminis-
tration of supplemental oxygen can be important with airway obstruction.
Progressive management may be necessary and would include repositioning of the 
patient’s airway by various opening manoeuvers, the placement of an airway tube to 
relieve upper airway obstruction or providing positive pressure ventilation.8 
Patients with serious medical emergencies can deteriorate quickly and urgent sup-
port of the airway, breathing and circulation are essential.9 Providers need to guide 
their treatment with the most recent resuscitation guidelines and must be certified 
in airway management.8
 
cOncLUSIOn
Protocols, guidelines and training are the essential cornerstones of out-of-theatre 
procedural sedation.10 Sedation practitioners must be trained and well-practiced in 
the art of providing safe sedation and resuscitation. They must be able to rescue a 
patient from a potential serious medical emergency and provide appropriate care 
until help arrives.
The 2015 SASA Guidelines on Procedural Sedation can be used as guidance for 
safe sedation practice.
Our next article will address ways to protect the airway during sedation.
References 
Analg A. Guidelines for the safe use of procedural sedation and analgesia for diagnostic 1. 
and therapeutic procedures in adults: 2010. 2010;16(4). 
Shavit I, Hershman E. Management of children undergoing painful procedures in 2. 
the emergency department by non-anesthesiologists. Isr Med Assoc J [Internet]. 
2004;6(6):350–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15214463
Campbell K, Torres L, Stayer S. Anesthesia and sedation outside the operating room. 3. 
Anesthesiol Clin [Internet]. Elsevier Inc; 2014;32(1):25–43. Available from: http://dx.doi.
org/10.1016/j.anclin.2013.10.010
Riou B, Ph D, Couloigner V. Case Scenario: Perianesthetic management of laryngos-4. 
pasm in children. Anesthesiology. 2012;116(2):458–71. 
Alalami AA, Ayoub CM, Baraka AS. Laryngospasm: review of different prevention and 5. 
treatment modalities. Pediatr Anesthesia. 2008;18(4):281–8. 
Visvanathan T, Kluger MT, Webb RK, Westhorpe RN. Crisis management during an-6. 
aesthesia: laryngospasm. Qual Saf Health Care [Internet]. 2005 Jun [cited 2015 Dec 
6];14(3):e3. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1
744026&tool=pmcentrez&rendertype=abstract
Becker DE, Haas DA. Recognition and management of complications during mod-7. 
erate and deep sedation. Part 2: Cardiovascular considerations. Anesth Prog. 
2011;58(3):126–38. 
Tobias J, Leder M. Procedural sedation: a review of sedative agents, monitoring, and 8. 
management of complications. Saudi J Anaesth. 2011;5(4):395. 
Part 10.6: Anaphylaxis. Circulation [Internet]. 2005 Nov 28 [cited 2015 Dec 28];112(24_9. 
suppl):IV – 143 – IV – 145. Available from: http://circ.ahajournals.org/content/112/24_
suppl/IV-143.full
D.L.R. Sedation of the pediatric patient. J Calif Dent Assoc [Internet]. 2013 [cited 2015 10. 
Dec 7];41(8):603–11. Available from: http://www.mendeley.com/research/sedation-pedi-
atric-patient-1/
Building on technology
Originally developed for bone regeneration,6 
NovaMinTM delivers calcium and phosphate into 
your patient’s enamel and dentine2,7,8 and provides 
favourable conditions for hydroxyapatite-like 
layer formation.
Building a 
reparative layer
From as quickly as the fi rst use, in vitro studies 
have shown a hydroxyapatite-like layer forming 
over exposed dentine and within the dentine 
tubules1-5 that is 50% harder than dentine.9
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Post-acidic challenge
In vitro SEM images of the tooth surface pre-brushing, of a 
reparative layer formed after twice-daily brushing for 4 days 
and of a reparative layer post a 5-minute acidic challenge.10
Building an integrated 
and resilient layer
The hydroxyapatite-like layer formed binds fi rmly 
to the collagen in the patient’s dentine5,11 and 
helps protect your patients from the chemical and 
physical oral challenges they encounter in their 
everyday lives.1,9,10,12
In vitro studies have shown that the robust layer 
builds up over 5 days10 and, with twice-daily 
brushing, provides patients with continual protection 
from dentine hypersensitivity.13–15
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